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Background: Unrestricted antibiotic use is very common in Iran. As a result, emergence 
of resistant organisms is commonplace. Antibiotic prophylaxis in surgery consists of a short 
antibiotic course given immediately before the procedure in order to prevent development of a 
surgical site infection. The basic principle of prophylaxis is to maintain effective concentrations 
of an antibiotic active against the commonest pathogens during the entire surgery.
Materials and methods: We prospectively investigated 427 urologic surgery cases in our 
department between August 2008 and September 2009 (Group1). As reference cases, we ret-
rospectively reviewed 966 patients who underwent urologic surgery between May 2004 and 
May 2008 (Group 2) who were administered antibiotics without any restriction. Prophylactic 
antibiotics such as cefazolin were administered intravenously according to our protocol. Post-
operative body temperature, peripheral white blood cell counts, urinalysis, and urine culture 
were checked.
Results: To judge perioperative infections, wound condition and general condition were 
evaluated in terms of surgical site infection, as well as remote infection and urinary tract 
infection, up to postoperative day 30. Surgical site infection was defined as the presence 
of swelling, tenderness, redness, or drainage of pus from the wound, superficially or 
deeply. Remote infection was defined as occurrence of pneumonia, sepsis, or urinary tract 
infection. Perioperative infection rates (for surgical site and remote infection) in Group 1 and 
Group 2 were nine of 427 (2.6%) and 24 of 966 (2.5%), respectively. Surgical site infection 
rates of categories A and B in Group 1 were 0 and two (0.86%), respectively, while those in 
Group 2 were 0 and five (0.92%), respectively. There was no significant difference in infection 
rates in terms of remote infection and surgical site infection between Group 1 and Group 2 
(P = 0.670). The amounts, as well as the prices, for intravenously administered antibiotics 
decreased to approximately one quarter.
Conclusion: Our protocol effectively decreased the amount of antibiotics used without increasing 
perioperative infection rates. Thus, our protocol of prophylactic antibiotic therapy can be recom-
mended as an appropriate method for preventing perioperative infection in urologic surgery. 
Keywords: surgical site infection, antibiotic prophylaxis, single dose, urologic surgery
Introduction
For more than two decades it has been claimed that prophylactic antibiotics are often 
inappropriately used in a variety of surgical procedures.1 Inappropriate antibiotic use 
increases environmental selection pressure, favoring the emergence of antimicrobial-
resistant bacteria that can cause surgical site infections, resulting in administration of 
more antibiotics, an increase in the cost of care, and a prolonged hospital stay.2 Surgical Therapeutics and Clinical Risk Management 2010:6 submit your manuscript | www.dovepress.com
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site infection is defined by the Centers for Disease Control 
and Prevention as an infection occurring at or near the surgi-
cal incision within 30 days of a procedure.3 Rates of surgical 
site infection are emerging as the leading indicator of quality 
in surgery. Attention to surgical site infection as a surrogate 
of quality, combined with the growing problem of antibiotic-
induced resistance, has brought the issue of prophylaxis to 
center stage. Antimicrobial prophylaxis is the periprocedural 
systemic administration of an antimicrobial agent intended 
to reduce the risk of local and systemic postprocedural infec-
tions. The potential benefit of antimicrobial prophylaxis is 
determined by patient-related factors (ability of the host to 
respond to bacterial invasion), procedural factors (likelihood 
of bacterial invasion at the operative site), and the potential 
morbidity of infection. Antimicrobial prophylaxis is recom-
mended only when the potential benefit outweighs the risks 
and anticipated costs (including expense of agent and admin-
istration, risk of allergic reactions or other adverse effects, 
and induction of bacterial resistance). The prophylactic agent 
should be effective against organisms characteristic of the 
operative site. Cost, safety, and convenience of the agent 
should also be considered. The duration of antimicrobial pro-
phylaxis should extend throughout the period when bacterial 
invasion is facilitated and/or likely to establish an infection.4 
There have been many reports and a comprehensive review 
on the prevention of surgical site infection and the use of 
antimicrobial prophylaxis in general surgery.5 However, in 
urologic surgery, only a few papers have been published, 
except for those on transurethral prostatectomy.6 The aim of 
the present study was to assess whether our antimicrobial 
prophylaxis protocol, which was designed to decrease the 
use of antibiotics as well as perioperative infection rates, 
was appropriate in urologic surgery in Iran.
Materials and methods
We prospectively investigated 427 patients who underwent 
urologic procedures at our center from August 2008 to 
  September 2009 (Group 1). A total of 1393 cases were 
analyzed, consisting of 427 cases in Group 1 and 966 cases 
in Group 2. The mean age of the two groups were 47 years 
(range 1–89) for Group 1 and 51.5 years (range 4–111) 
for Group 2. The number of patients in categories A and B 
were 196 and 231 in Group 1, and 428 and 538 in Group 2, 
respectively (Table 3). In each category, there were no statisti-
cally significant differences between Group A and Group B 
in terms of clinical background including age, gender, body 
mass index, hemoglobin, smoking, operation time, and 
Table 1 number of adult and pediatric cases
Group 1 Group 2 Total
Adult 391 866 1257
Pediatric  36 100 136
bleeding (Table 1). We classified our surgical operations into 
two categories according to invasiveness and contamination 
level, ie, category A (clean and less invasive surgery, eg, 
endoscopic surgery) and category B (clean invasive surgery 
or clean contaminated surgery, Table 5). Patients with sys-
temic or local signs and symptoms of infection were excluded 
from the study. Urinalysis and urine culture were performed 
for all of our eligible cases. Cases of positive or suspicious 
urine culture before operation were also excluded. Antibiotics 
were administered intravenously according to our protocol, 
ie, cefazolin during the induction of anesthesia for both cat-
egories. All of the endourologic cases, except for cystoscopy, 
had insertion of an indwelling Foley catheter for at least 
24 hours postoperatively. In addition, we inserted an indwell-
ing Foley catheter postoperatively for cases of open simple 
or radical prostatectomy, open pyelolithotomy or nephro-
lithotomy, radical nephrectomy or partial nephrectomy, and 
ureterolithotomy. Postoperative oral antibiotics were not 
initially administered. The occurrence of surgical site infec-
tion and remote infection in Group 1 was compared with the 
retrospectively reviewed reference group of 966 cases who 
underwent urologic surgery with uncontrolled administration 
of antibiotics from March 2006 to April 2008 (Group 2). We 
also analyzed risk factors for surgical site infection or remote 
infection in Group 1, including preoperative patient factors 
(age, gender, body mass index, smoking status, diabetes 
mellitus, hypertension, and hemoglobin concentration), and 
intraoperative conditions (duration of surgery and amount of 
bleeding). In Group 2, intravenous cefazolin was given for 
24–48 hours after surgery and in Group 1 only a single-dose 
intravenous cefazolin dose was given at the time of operation. 
In all cases, including both groups, the preoperative hospital 
stay was less than 24 hours. The new one-dose protocol 
required that cefazolin 1 g would be given at induction of 
anesthesia. No doses would be given after the end of surgery. 
All patients were visited on postoperative days 2 and 4. If 
local or systemic signs or symptoms of infection, including 
fever, tenderness, and/or swelling at the incision site were 
detected, an appropriate oral or intravenous antibiotic was 
commenced. In addition, complete blood count, urinalysis, 
and urine culture were performed 24 hours after operation and 
48 hours after Foley catheter removal. The approximate cost Therapeutics and Clinical Risk Management 2010:6 submit your manuscript | www.dovepress.com
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of a cefazolin 1 g vial was 1 USD. When a patient showed 
signs of systemic infection, ie, body temperature $38°C, a 
white blood cell count .12,000/mm,3 or localized signs or 
symptoms including pain, swelling, redness, wound drainage, 
and tenderness, treatment using another appropriate antibiotic 
was started, and the case judged as a failure to prevent peri-
operative infection.
statistical analysis
SPSS software (version 16; SPSS Inc., Chicago, IL) was 
used for the statistical analysis. A P value of less than 0.05 
was considered significant.
Results
Perioperative infections, including surgical site infection and 
remote infection, were observed up to 30 days postoperation. 
We primarily judged perioperative infections from the wound 
condition and general condition at the second or fourth 
day after operation. Perioperative infection, including both 
  surgical site infection and remote infection, occurred in nine 
of 427 patients (2.6%) in Group 1 and in 24 of 966 (2.5%) in 
Group 2 (Table 4). There was no statistically significant dif-
ference in perioperative infection rates between Group 1 and 
Group 2 (P = 0.670). Rates of surgical site infection in Group 
1 were 0 and 2 (0.86%) in categories A and B, respectively, 
while those in Group 2 were 0 and 5 (0.92%), respectively. 
Again, there was no statistically significant difference in 
the rate of surgical site infection in each category between 
Group A and Group B (P = 0.670 and P = 0.667, respectively, 
Table 2). In categories A and B, the amount of intravenously 
administered antibiotics per patient in Group 1 was sig-
nificantly smaller than that in Group B. Thus, the average 
price for intravenously administered antibiotics decreased 
to approximately one quarter (1 USD for Group 1 versus 4 
USD for Group 2) and the average price for oral antibiotics 
decreased to approximately one-fifth (0.5 USD for Group 
1 and 2 USD for Group 2). No significant differences were 
found between the single-dose group and the two-day group 
in terms of total surgical site infection, superficial incisional 
surgical site infection, deep incisional surgical site infection, 
febrile urinary tract infections, or pneumonia. In both groups, 
underlying conditions, such as diabetes, did not have an influ-
ence on the incidence of postoperative complications.
Discussion
Surgical site infection and urinary tract infection are a 
  common cause of patient morbidity. Surgical site infections 
complicate up to 5% of clean extra-abdominal operations 
and up to 20% of intra-abdominal procedures.7 There are 
many potential factors to consider in choosing an appropriate 
  perioperative antibiotic regimen. These considerations 
include the infection rate at both the surgical site and at 
remote sites, the potential development of antimicrobial 
resistance, cost, and the potential for adverse reactions to 
the antibiotic. Surgical site infections increase morbidity 
and mortality and can incur considerable costs to an already 
overwhelmed health care system. Surgical antimicrobial 
prophylaxis has been shown to reduce the incidence of 
postoperative wound infections in many randomized clinical 
trials. The drug chosen should be active against the pathogens 
most commonly associated with wound infections following 
the specific procedure and against the pathogens endogenous 
to the region of the body being operated on,8 but need not be 
active against every potential pathogen.9 The prophylactic 
dose should never be smaller than the standard therapeutic 
dose of the drug. It is reasonable to use a dose in the upper 
therapeutic range (eg, 1–2 g of cefazolin or cefotetan for 
adults and 30–40 mg/kg for children).
Infection can be prevented when effective concentrations 
are present in the blood and tissues during and shortly after 
Table 2 Clinical background and data for group 1 and group 2
Group 1 Group 2
Category A Category B Category A Category B
Cases (n) 196 231 428 538
Median age 44.2 53.5 47.5 51.7
BMi, median (range) 22 (18–27) 23.5 (19–31) 21 (18.5–28) 24 (18–30)
sex, female/male 17/179 19/212 41/387 80/458
Median hb (range, g/dL) 13 13.5 14 13.8
smoking, yes/no 57/139 64/167 132/296 161/377
hypertension 28/168 42/189 87/341 114/424
Diabetes mellitus 14/182 51/180 47/381 92/446
Abbreviations: BMi, body mass index; hb, hemoglobin.Therapeutics and Clinical Risk Management 2010:6 submit your manuscript | www.dovepress.com
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the surgical procedure. Therefore, antimicrobial prophylaxis 
should begin just before the operation. Starting earlier is 
unnecessary and potentially dangerous, and starting later is 
less effective.9 Current information indicates that   additional 
intraoperative doses of an antimicrobial agent should 
be given at intervals of one- or two-fold the half-life of 
the drug so that adequate levels are maintained throughout 
the operation.10 Because the half-life of almost all antibiot-
ics is 0.7–1.5 hours, it is necessary to administer antibiotics 
again when the operation time is more than three hours.11 
Supplementary doses are indicated in cases where blood 
loss is greater than 1500 cc.
Misuse of antibiotics is not harmless. Increasing adverse 
effects, bacterial resistance, and costs are commonly associated 
with antibiotic use. To our knowledge, no one has demonstrated 
an increase in adverse effects using surgical antibiotic pro-
phylaxis. Many risk factors have been reported, such as age, 
nutritional status, diabetes mellitus, smoking, and obesity,12 as 
well as coexistent infections at a remote body site, colonization 
with microorganisms, altered immune response, length of 
preoperative stay, transfusion, preoperative hair removal, 
antimicrobial prophylaxis, operating room, surgical attire and 
drapes, and surgical technique.
Taken together, we classified surgical procedures 
according to invasiveness, contamination levels (Table 5), 
and antimicrobial prophylaxis schedule, including timing, 
period, and the selection of antimicrobial agents designed 
according to each category. Because the targets are not 
only Gram-positive but also Gram-negative bacteria in 
category B, first- or second-generation cephems for skin 
incisions are recommended.8
We believe that our protocol was very simple for 
medical staff to implement. Most importantly, there were 
no   significant differences in the rates of surgical site infec-
tion as well as remote infection in each category between 
the two groups, in spite of a decrease in the amount of 
antimicrobial prophylaxis. In a study by Briffaux et al there 
was no significant difference between two antibiotic pro-
phylaxis regimens (single-dose or three-day) for patients 
undergoing transrectal ultrasound-guided biopsies.13 In a 
study by Zomorrodi and Buhluli14, there was no difference 
between 1 day and 7 days antibiotic prophylaxis in donor 
nephrectomy cases. In a study by Trinchieri et al antimi-
crobial prophylaxis according to European Association 
of Urology guidelines together with active surveillance 
seemed to be adequate to prevent symptomatic/febrile 
genitourinary infections, as well as serious wound infec-
tions, in the majority of patients.15
An appealing argument for decreasing antibiotic 
usage may involve cost. Our study showed that adjusting 
24-hour prophylaxis to one dose-prophylaxis reduces costs 
without increasing infection rates, and results in monthly 
cost savings. Importantly, our savings are not restricted to 
decreasing two to three doses per surgery, considering that 
overuse of antibiotics may be much more expensive than 
the cost of the drug itself. Resistant organisms, potential 
allergic reactions, and other adverse events related to 
antibiotic use will certainly cost more than the 3 USD per 
Table 4 infection rates in group 1 and group 2
Group 1 Group 2
Category n SSI (%) RI (%) Total (%) n SSI (%) RI (%) Total (%)
A 196 0 3 (1.5) 3 (1.5) 428 0 9 (2) 9 (2)
B 231 2 (0.86) 4 (1.7) 6 (2.5) 538 5 (0.92) 10 (1.8) 15 (2.72)
Total 427 2 (0.46) 5 (1.2) 9 (2.6) 966 5 (0.5) 19 (2) 24 (2.5)
Abbreviations: ssi, surgical site infection; Ri, remote infection.
Table 3 Major operation types of groups and categories
Category A Group 1 Group 2 Category B Group 1  Group 2
TURP 63 72 sOP 67 143
TUL 74 75 Oss 31 58
TURB 21 31 nephrectomy 11 29
iU 14 16 Varicocelectomy 53 131
PB 4 10 herniorrhaphy 34 87
BB 7 5 hydrocelectomy 35 69
CLL 13 22 Open cystolithotomy 8 21
Total 196 231 Total 239 538
Abbreviations: BB, bladder biopsy; CLL, cystolitholapaxy; iU, internal urethrotomy; Oss, open stone surgery; PB, prostate biopsy; sOP, suprapubic open prostatectomy; 
TUL, transuretheral lithotripsy; TURB, transurethral resection of bladder; TURP, transurethral resection of prostate.Therapeutics and Clinical Risk Management 2010:6 submit your manuscript | www.dovepress.com
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vial of cefazolin. In countries with limited resources, such 
as Iran, even modest savings can have an impact. Evans 
et al16 reported recently that the median cost of treating a 
resistant Gram-negative infection in a surgical intensive 
care unit was 80,500 USD compared with the cost of 
treating a patient with a sensitive Gram-negative infection, 
which was 29,604 USD (P , 0.001). These authors have 
concluded that “… efforts to control overuse of antibiotics 
should be pursued”.17
Conclusion
A single-dose antimicrobial prophylaxis regimen was 
effective for prevention of perioperative infections, including 
surgical site infection, urinary tract infection, and remote 
infection in endoscopic-instrumental, clean, and clean-
contaminated surgical procedures in urologic patients. We 
have demonstrated that single-dose prophylaxis is feasible. 
To the best of our knowledge, this is the first reported study 
from Iran to evaluate the role of antimicrobial prophylaxis 
in urologic surgery. In the current era of restricted hospital 
budgets, one-dose prophylaxis may provide a way to improve 
performance by lowering costs.
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